Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Fauvelle

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Plos One|March 8, 2017
A meta-analysis of home range studies in the context of trophic levels: Implications for policy-based conservationCatherine Fauvelle, Rianne Diepstraten, Tyler Jessen
Cell Research|March 15, 2014
Unraveling hepatitis C virus structureCatherine Fauvelle, Daniel J Felmlee, Thomas F Baumert
Journal of Hepatology|December 3, 2014
A prophylactic hepatitis C virus vaccine: a distant peak still worth climbingThomas F Baumert, Catherine Fauvelle, Diana Y Chen, et al.
Virologie (Montrouge, France)|September 24, 2022
[Hepatitis C virus and neutralizing antibodies]Catherine Fauvelle, Laura Heydmann, Mirjam B Zeisel, et al.
Hepatology International|July 13, 2017
A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entryCatherine Fauvelle, Melanie Lambotin, Laura Heydmann, et al.
The Journal of General Virology|August 3, 2013
Role of seipin in lipid droplet morphology and hepatitis C virus life cycleSophie Clément, Catherine Fauvelle, Emilie Branche, et al.
Expert Review of Vaccines|June 9, 2016
Hepatitis C virus vaccine candidates inducing protective neutralizing antibodiesCatherine Fauvelle, Che C Colpitts, Zhen-Yong Keck, et al.
Microbial Pathogenesis|March 19, 2013
Hepatitis C virus vaccines--progress and perspectivesCatherine Fauvelle, Quentin Lepiller, Daniel J Felmlee, et al.
Viruses|December 4, 2012
Neutralizing antibodies and pathogenesis of hepatitis C virus infectionSamira Fafi-Kremer, Catherine Fauvelle, Daniel J Felmlee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine designBrian G Pierce, Zhen-Yong Keck, Patrick Lau, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Plos One|March 8, 2017
A meta-analysis of home range studies in the context of trophic levels: Implications for policy-based conservationCatherine Fauvelle, Rianne Diepstraten, Tyler Jessen
Cell Research|March 15, 2014
Unraveling hepatitis C virus structureCatherine Fauvelle, Daniel J Felmlee, Thomas F Baumert
Journal of Hepatology|December 3, 2014
A prophylactic hepatitis C virus vaccine: a distant peak still worth climbingThomas F Baumert, Catherine Fauvelle, Diana Y Chen, et al.
Virologie (Montrouge, France)|September 24, 2022
[Hepatitis C virus and neutralizing antibodies]Catherine Fauvelle, Laura Heydmann, Mirjam B Zeisel, et al.
Hepatology International|July 13, 2017
A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entryCatherine Fauvelle, Melanie Lambotin, Laura Heydmann, et al.
The Journal of General Virology|August 3, 2013
Role of seipin in lipid droplet morphology and hepatitis C virus life cycleSophie Clément, Catherine Fauvelle, Emilie Branche, et al.
Expert Review of Vaccines|June 9, 2016
Hepatitis C virus vaccine candidates inducing protective neutralizing antibodiesCatherine Fauvelle, Che C Colpitts, Zhen-Yong Keck, et al.
Microbial Pathogenesis|March 19, 2013
Hepatitis C virus vaccines--progress and perspectivesCatherine Fauvelle, Quentin Lepiller, Daniel J Felmlee, et al.
Viruses|December 4, 2012
Neutralizing antibodies and pathogenesis of hepatitis C virus infectionSamira Fafi-Kremer, Catherine Fauvelle, Daniel J Felmlee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine designBrian G Pierce, Zhen-Yong Keck, Patrick Lau, et al.
Pageof 2